OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

What’s Going On With AMD Stock Monday?

What’s Going On With AMD Stock Monday?

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting

December 10, 2019

A handful of sickle cell disease treatments and CAR-T therapies that treat cancer have been approved by the Food and Drug Administration in recent years, but a...

3rdPartyFeeds

US STOCKS-Wall Street slips as tariff deadline closes in

December 10, 2019

Wall Street's main stock indexes ended slightly lower on Tuesday, though not far from record highs, as investors awaited concrete news on whether a new round...

3rdPartyFeeds

Alphabet Roundup: CEO Pichai, Labor Trouble, Digital Tax in Europe, Verily, Waymo

December 10, 2019

The biggest news from last week is Google CEO Sundar Pichai taking over as CEO of Alphabet as well, and it was accompanied by other news covering labor...

3rdPartyFeeds

Attorney General Barr Says He Wants Antitrust Investigation Into Tech Giants Finished Next Year

December 10, 2019

U.S. Attorney General William Barr has signaled he wants to finish the antitrust investigation into U.S. technology giants next year. “I think it’s important...

3rdPartyFeeds • News

FA Center: These books aren’t about money— but they can change how you think about it

December 10, 2019

Financial planners have learned about themselves from these authors, and you can too.

Read More...

3rdPartyFeeds

Facebook under fire as political ads vanish from archive – FT

December 10, 2019

Thousands of political ads have gone missing from Facebook Inc's public archive less than 48 hours before the British general election, the Financial Times...

3rdPartyFeeds

US STOCKS-Wall Street flat as tariff deadline nears

December 10, 2019

Wall Street's main stock indexes were little changed on Tuesday, hovering near record highs, as investors awaited concrete news on whether U.S. tariffs on...

3rdPartyFeeds • News

Outside the Box: Americans keep gorging on debt, thanks to the Federal Reserve

December 10, 2019

Even only a slight increase in interest rates creates millions more in interest payments for consumers.

Read More...

3rdPartyFeeds • News

The Ratings Game: Netflix could lose 4 million U.S. subscribers next year, warns analyst

December 10, 2019

Netflix Inc. historically has been averse to advertisements, but the changing competitive landscape in streaming likely warrants a change in strategy...

3rdPartyFeeds

Amazon issues fix after some Blink home cameras found vulnerable to hacking

December 10, 2019

Read More...

Previous 1 … 7,047 7,048 7,049 7,050 7,051 … 8,351 Next
Indices by TradingView
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

August 26, 2025
Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

Form 8.3 – Aqua Acquisition Sub LLC (subsidiary of Qualcomm Incorporated)

August 26, 2025
Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

Earnings To Watch: Nvidia (NVDA) Reports Q2 Results Tomorrow

August 25, 2025
Fox channels may go dark on YouTube TV from Wednesday over payment dispute

Fox channels may go dark on YouTube TV from Wednesday over payment dispute

August 25, 2025
Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

Inside Elon Musk’s suit against Apple and OpenAI: ‘This is a tale of two monopolists’

August 25, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.